Skip to Main Content

NCI Sponsors Medical Image De-Identification Benchmark Challenge

June 12, 2024
The National Cancer Institute (NCI) is sponsoring the Medical Image De-Identification Benchmark Challenge. The challenge invites developers to evaluate their digital imaging and communications in medicine (DICOM) image de-identification tools, emphasizing automated methods that maintain research utility. By utilizing diverse medical imaging data from the NCI’s Cancer Imaging Archive, participants can contribute to the MIDI-B Challenge report as co-authors. Top teams will be given the opportunity to present their algorithms and results at the Medical Imaging Computing and Computer Assisted Intervention (MICCAI) 2024 virtual session, fostering advancements in medical imaging and AI.

NCI encourages all developers (independent, academic or industrial) who want to assess their software tool’s performance with rule-based de-identification of DICOM images to register. The registration deadline for the challenge is Aug. 15.

For more information, contact Katie Grady, American College of Radiology® Government Affairs Director.

Related ACR News

  • Make America Healthy Again

    President Trump released an Executive Order (EO) establishing the "Make America Healthy Again (MAHA) Commission,” Feb. 13 to be led by the new Department of Health and Human Services Secretary Robert F. Kennedy Jr.

    Read more

  • Scope of Practice Bills Introduced At State Legislative Level

    The American College of Radiology® (ACR®) is tracking more than 58 scope of practice bills across 22 states with more expected to be considered.

    Read more

  • ACR Others Challenge MAC Position on Minimally Invasive Arthrodesis of the Sacroiliac Joint

    The American College of Radiology® (ACR®) and other medical specialty societies that use or perform interventional pain and spine procedures told three of the seven Medicare Administrative Contractors (MACs) that implementation of a new policy as written could limit access to a safe, effective and durable treatment option, potentially exacerbating healthcare disparities among Medicare patients.

    Read more